2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review

By S. Gould, R. Scott. 2005

707 citations recorded by the source corpus.

Subfields: Molecular Biology, Pediatrics, Perinatology and Child Health, Pharmaceutical Science

View Paper: https://www.semanticscholar.org/paper/2b709baa97312640a8d0c5c24a545f83a6a6d755

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. W. Charman
2. M. Brewster
3. Colin W. Pouton
4. Christopher J. H. Porter
5. S. Charman
6. H. Williams
7. R. Shanker
8. T. Loftsson

In Pediatrics, Perinatology and Child Health

1. W. Charman
2. M. Brewster
3. Colin W. Pouton
4. Christopher J. H. Porter
5. S. Charman
6. H. Williams
7. R. Shanker
8. T. Loftsson

In Pharmaceutical Science

1. Christopher J. H. Porter
2. M. Brewster
3. W. Charman
4. Natalie L. Trevaskis
5. R. Shanker
6. S. Charman
7. H. Williams
8. Colin W. Pouton

Citations in the corpus

• Strategies to Address Low Drug Solubility in Discovery and Development (2013, background): “However, as cholecystokinin shows no mitogenic effects in humans and other species, the effects of HP-b-CD on the pancreas may be specific to the rat (Gould and Scott, 2005).”
• Cyclodextrins as pharmaceutical solubilizers. (2007, background): “HPβCD is much more water-soluble and more toxicologically benign than the natural βCD [43,44].”